Kelsey Heckmann
Psychiatric/Mental Health · Newark, NJNPI 1275241739
Payments from drug & device makers
Across 182 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$743
- Teva Pharmaceuticals USA, Inc.$540
- Johnson & Johnson$493
- Lundbeck LLC$394
- AbbVie$329
- Otsuka America Pharmaceutical, Inc.$173
- plus $330 from 8 others
What the payments were for
- Food & beverage$3,002100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 46 | $743 |
| Teva Pharmaceuticals USA, Inc. | 32 | $540 |
| Johnson & Johnson | 32 | $493 |
| Lundbeck LLC | 23 | $394 |
| AbbVie | 19 | $329 |
| Otsuka America Pharmaceutical, Inc. | 10 | $173 |
| Neurocrine Biosciences, Inc. | 6 | $94 |
| E.r. Squibb & Sons, L.L.C. | 3 | $56 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Tris Pharma Inc | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Merck | 1 | $13 |
How this compares
$3,002 in reported general payments places this provider in the 85th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $98,978 |
| FanaptIloperidone | 12 | $39,883 |
| VraylarCariprazine Hcl | 24 | $37,595 |
| Aripiprazole | 53 | $7,477 |
| Quetiapine Fumarate | 90 | $1,173 |
| Bupropion XlBupropion Hcl | 42 | $1,082 |
| Haloperidol | 13 | $933 |
| Trazodone Hcl | 115 | $839 |
| Divalproex Sodium ErDivalproex Sodium | 14 | $807 |
| Clonazepam | 84 | $681 |
| Sertraline Hcl | 117 | $554 |
| Benztropine Mesylate | 44 | $482 |
| Risperidone | 36 | $386 |
| Mirtazapine | 23 | $299 |
| Lamotrigine | 19 | $288 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $94 | $98,97813 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $30 | $39,88312 claims |
| AbbVieVraylar | $329 | $37,59524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Other psychiatric/mental health in Newark
- Regina InokonNewark$7K
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.